Fleury profit grows 40% in the second quarter 2016
Lucro do Fleury cresce 40% no segundo trimestre de 2016
Intel ID : 239159
| Synopsis |
|
Fleury (BVMF: FLRY3), a diagnostic medicine company headquartered in São Paulo, recorded a net profit of BRL 46.1m in the second quarter of 2016, a 40.2% increase compared to the same period in 2015, reported Valor Econômico on 28 July, 2016, citing a company's statement. The result benefited from the gross revenue increase, tax deductions and cancellations' reduction. Excluding the impact of deferred taxes, profit would be BRL 57.8m. In the same comparison basis, revenue grew 9.5%, from BRL 479.5m to BRL 525.1m.
(content in portuguese)
O Fleury (BVMF:FLRY3), empresa de medicina diagnóstica com sede em São Paulo, registrou um lucro líquido de BRL 46,1m no segundo trimestre de 2016, o que representa um aumento de 40,2% em relação ao mesmo período de 2015, segundo publicou o Valor Econômico no dia 28 de julho de 2016, citando uma publicação da empresa. O resultado foi beneficiado pelo aumento na receita bruta, nas deduções em impostos e pela redução dos cancelamentos. Excluindo o impacto dos impostos diferidos, o lucro seria de BRL 57,8m. Na mesma base de comparação, a receita cresceu 9,5%, passando de BRL 479,5m para BRL 525,1m. |
|
||||
| Intel ID | 239159 | |
| Value | ND | |
| Native Currency |
Brazilian Real (BRL)
Exchange Rate:  |
|
|
Financial Data - Fleury
(31 Dec 2024) |
Revenue: - EBITDA: - Net Debt: - |
|
| Date |
 |
|
| Country | |
|
| Region | ||
| Continent | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.03.03 Diagnostic, Imaging & Laboratory Services 30 Healthcare / 30.03 Healthcare Facilities & Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.